Literature DB >> 9864397

Alteration of caspase-3 (CPP32/Yama/apopain) in wild-type MCF-7, breast cancer cells.

H Kurokawa1, K Nishio, H Fukumoto, A Tomonari, T Suzuki, N Saijo.   

Abstract

Caspase-3 (CPP32/Yama/apopain), one of the interleukin 1 -converting enzyme (ICE)-like proteases (caspases), is anticipated to mediate apoptotic cell death. We observed the expression of caspase-3 in various cancer cell lines and lack of normal expression of mRNA and protein in MCF-7, human breast carcinoma cell line. Sequence analysis of cDNA showed 125 nucleotides deletion in spite of no gross gene alteration of caspase-3 in MCF-7. The possible cause is altered splicing of the fragment followed by frame shift at translation level. MCF-7 cells are widely used in the research of apoptosis because of the high sensitivity to tumor necrosis factor induced cell death. However, our results suggest the existence of other apoptotic pathways independent on caspase-3 at least in MCF-7 cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9864397     DOI: 10.3892/or.6.1.33

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  32 in total

1.  An anticancer agent icaritin induces sustained activation of the extracellular signal-regulated kinase (ERK) pathway and inhibits growth of breast cancer cells.

Authors:  YuMing Guo; XinTian Zhang; Jun Meng; Zhao-Yi Wang
Journal:  Eur J Pharmacol       Date:  2011-03-01       Impact factor: 4.432

2.  Linking sister chromatid cohesion and apoptosis: role of Rad21.

Authors:  Debananda Pati; Nenggang Zhang; Sharon E Plon
Journal:  Mol Cell Biol       Date:  2002-12       Impact factor: 4.272

3.  CASP 3 genetic polymorphisms and risk of Hepatocellular carcinoma: a case-control study in a Chinese population.

Authors:  Benyuan Deng; Fei Liu; Limei Luo; Yonggang Wei; Bo Li; Hanteng Yang
Journal:  Tumour Biol       Date:  2016-01-12

4.  Targeted destruction of DNA replication protein Cdc6 by cell death pathways in mammals and yeast.

Authors:  Frederic Blanchard; Michael E Rusiniak; Karuna Sharma; Xiaolei Sun; Ivan Todorov; M Mar Castellano; Crisanto Gutierrez; Heinz Baumann; William C Burhans
Journal:  Mol Biol Cell       Date:  2002-05       Impact factor: 4.138

5.  A functional variant at the miR-885-5p binding site of CASP3 confers risk of both index and second primary malignancies in patients with head and neck cancer.

Authors:  Xiaoxiang Guan; Zhensheng Liu; Hongliang Liu; Hongping Yu; Li-E Wang; Erich M Sturgis; Guojun Li; Qingyi Wei
Journal:  FASEB J       Date:  2012-12-27       Impact factor: 5.191

Review 6.  Cohesin subunit RAD21: From biology to disease.

Authors:  Haizi Cheng; Nenggang Zhang; Debananda Pati
Journal:  Gene       Date:  2020-07-17       Impact factor: 3.688

7.  Dexamethasone inhibits TNF-alpha-induced apoptosis and IAP protein downregulation in MCF-7 cells.

Authors:  U K Messmer; C Pereda-Fernandez; M Manderscheid; J Pfeilschifter
Journal:  Br J Pharmacol       Date:  2001-06       Impact factor: 8.739

8.  CASP3 polymorphisms and risk of squamous cell carcinoma of the head and neck.

Authors:  Kexin Chen; Hui Zhao; Zhibin Hu; Li-E Wang; Wei Zhang; Erich M Sturgis; Qingyi Wei
Journal:  Clin Cancer Res       Date:  2008-10-01       Impact factor: 12.531

9.  Wortmannin induces MCF-7 breast cancer cell death via the apoptotic pathway, involving chromatin condensation, generation of reactive oxygen species, and membrane blebbing.

Authors:  Rozina Akter; Md Zakir Hossain; Maurice G Kleve; Michael A Gealt
Journal:  Breast Cancer (Dove Med Press)       Date:  2012-07-13

10.  The Amaryllidaceae isocarbostyril narciclasine induces apoptosis by activation of the death receptor and/or mitochondrial pathways in cancer cells but not in normal fibroblasts.

Authors:  Patrick Dumont; Laurent Ingrassia; Sébastien Rouzeau; Fabrice Ribaucour; Stéphanie Thomas; Isabelle Roland; Francis Darro; Florence Lefranc; Robert Kiss
Journal:  Neoplasia       Date:  2007-09       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.